Literature DB >> 6421555

Treatment of pyoderma gangrenosum with disodium cromoglycate.

B Saffouri, B M Hom, J M Mertesdorf, J E Gardiner.   

Abstract

The case of a 35-year-old black woman with a 10-year history of ulcerative colitis and a 3-year history of pyoderma gangrenosum is presented. The pyoderma gangrenosum was treated successfully with topical application of disodium cromoglycate.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6421555     DOI： 10.1007/bf01317063

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  10 in total

1.  Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

Authors:  N A Buckell; S R Gould; D W Day; J E Lennard-Jones; A M Edwards
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

2.  Pyoderma gangrenosum; a clinical study of nineteen cases.

Authors:  H O PERRY; L A BRUNSTING
Journal:  AMA Arch Derm       Date:  1957-03

3.  Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins.

Authors:  J S Cox; T S Orr; M C Pollard; J Gwilliam
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

4.  The treatment of pyoderma gangrenosum with sodium cromoglycate.

Authors:  K M de Cock; M G Thorne
Journal:  Br J Dermatol       Date:  1980-02       Impact factor: 9.302

5.  Clofazimine. A new agent for the treatment of pyoderma gangrenosum.

Authors:  G Michaëlsson; L Molin; S Ohmann; L Gip; B Lindström; M Skogh; I Trolin
Journal:  Arch Dermatol       Date:  1976-03

6.  The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients.

Authors:  A J Greenstein; H D Janowitz; D B Sachar
Journal:  Medicine (Baltimore)       Date:  1976-09       Impact factor: 1.889

7.  Disodium cromoglycate in the treatment of chronic proctitis.

Authors:  R V Heatley; B J Calcraft; J Rhodes; E Owen; B K Evans
Journal:  Gut       Date:  1975-07       Impact factor: 23.059

8.  Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis.

Authors:  P J Holt; M G Davies; K C Saunders; G Nuki
Journal:  Medicine (Baltimore)       Date:  1980-03       Impact factor: 1.889

9.  Pyoderma gangrenosum associated with active chronic hepatitis: report of two cases.

Authors:  J P Byrne; M Hewitt; R Summerly
Journal:  Arch Dermatol       Date:  1976-09

10.  The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.

Authors:  L Molin; O Stendahl
Journal:  Acta Med Scand       Date:  1979
  10 in total
  1 in total

1.  'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis.

Authors:  A D Dwarakanath; L G Yu; C Brookes; D Pryce; J M Rhodes
Journal:  Gut       Date:  1995-10       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.